• January 2017 – 340B INSIDER

    Welcome to the January edition of RxStrategies 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view. LET’S CONNECT DURING THE 340B WINTER CONFERENCE The RxStrategies’ team is ready to connect with 340B leaders at the 13th Annual 340B Coalition Winter Conference, February 1 – 3 in San Francisco. We are proud to be a Pinnacle… Read more »

  • Is 340B Program Management Leaving You Fragmented?

    RxStrategies 340BPlus Split Billing Solution helps to remove the complexity of 340B program management by reviewing all prescription activity to flag eligible 340B dispenses. All activity is then designated for proper replenishment, (GPO, WAC, 340B) auditability and reporting.   RxStrategies’ 340BPlus Split Billing Solution:   Maximizes your savings by assuring data integrity via an automated… Read more »

  • 340B Program Compliance. Be Audit Ready.

    RxStrategies works with Covered Entities to provide an integrated approach to streamline the delivery of quality care, while maximizing savings and meeting the regulatory challenges associated with 340B program management. RxStrategies’ 340B solutions are key to a comprehensive and compliant 340B program.   RxStrategies’ CompliancePlus Audit Solution (Self-Audits Portal):   Implement internal processes, controls and… Read more »

  • NOVEMBER 2016 – 340B INSIDER

    Welcome to the November edition of RxStrategies 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view. AFFORDABLE CARE ACT – WHAT IS ON THE HORIZON RxStrategies works closely with a number of industry thought leaders to keep a pulse on issues potentially impacting the 340B Drug Pricing Program. With… Read more »

  • RxStrategies at the CPCA Annual Conference

    We will be networking with California’s community clinic and health center leaders during the California Primary Care Association’s Annual Conference in Long Beach, from October 27 – 28, to learn about the challenges they face when managing a compliant 340B program.   Connect with RxStrategies, visit our booth or schedule a 340B CompliancePlus demo.

  • Make the Right 340B Choice. Let’s Connect During OKPCA Conference!

    Maintaining a compliant 340B program can be a challenge. Connect with Todd Hudnall and the RxStrategies team during the OKPCA Annual Conference, from October 26 – 28 in Oklahoma City, to learn how Federally Qualified Community Health Centers can achieve better health outcomes and a greater quality of care with our 340B program solutions. Schedule an appointment… Read more »

  • HCP 2016 Fall Hospital Pharmacy Conference

    President and Chief Executive Officer Fenton Markevich and Chief Revenue Officer Skip Devanny will be representing RxStrategies at the 2016 Fall Hospital Pharmacy Conference, October 17 – 19 in Chicago. We are looking forward to connecting with Hospital Pharmacy Directors from America’s most prestigious hospitals and health systems during the Supplier Showcase booth #406 and… Read more »

  • Join RxStrategies at the 2016 GAPHC Annual Conference

    Chief Operating Officer Time Vroman, Rhodie Smith and the RxStrategies team will be networking with community health center leaders during the GAPHC 2016 Annual Conference at the Grand Hyatt in Atlanta. This year’s conference will focus on the continuing advancements in healthcare for those serving Georgia’s medically underserved population. Ready to connect with a 340B… Read more »

  • Clinical Insights — September 2016 Issue

    Welcome to the September edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval Amjevita™ (adalimumab-atto) – September 23, 2016 – The U.S. Food and Drug Administration (FDA) approved Amjevita™ (adalimumab-atto) as a biosimilar to Humira® (adalimumab) for multiple inflammatory diseases. Read More.… Read more »